Use of data from the Vascular Quality Initiative registry to support regulatory decisions yielded a high return on investment
Background Real-world data (RWD) from the Society for Vascular Surgery Vascular Quality Initiative (VQI) registry has been used to support US Food and Drug Administration (FDA) regulatory decisions regarding vascular devices. The variables of cost and time needed for these registry-based studies hav...
Main Authors: | Art Sedrakyan, Gregory Pappas, Erika Avila-Tang, Danica Marinac-Dabic, Jack L Cronenwett, Adam W Beck, Daniel Bertges, Jens Eldrup-Jorgensen, Frederic S Resnic, Nadezda Radoja, Andreas Schick, Josh Smale, Roberta A Bloss, Peter Phillips, Melissa Hasenbank, Shengchun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Surgery, Interventions, & Health Technologies |
Online Access: | https://sit.bmj.com/content/2/1/e000039.full |
Similar Items
-
Authors’ response
by: Jack L Cronenwett, et al.
Published: (2020-11-01) -
Development of a coordinated registry network for pelvic organ prolapse technologies
by: Art Sedrakyan, et al.
Published: (2022-11-01) -
Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
by: David S Liebeskind, et al.
Published: (2022-11-01) -
Developing the foundation for assessment of Devices used for Acute Ischemic Stroke Interventions (DAISI) using a Coordinated Registry Network
by: David S Liebeskind, et al.
Published: (2022-11-01) -
Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies
by: Michael Mack, et al.
Published: (2019-07-01)